144 related articles for article (PubMed ID: 38176501)
1. Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy.
Qiao Y; Shi Y; Ji M; Wang Z; Bai X; Zhang K; Yin K; Zhang Y; Chen X; Zhang Y; Lu J; Zhao J; Liu K; Yuan B
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129002. PubMed ID: 38176501
[TBL] [Abstract][Full Text] [Related]
2. DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin β1 as a Molecular Target.
Zhang Y; Chen X; Qiao Y; Yang S; Wang Z; Ji M; Yin K; Zhao J; Liu K; Yuan B
Anal Chem; 2022 Dec; 94(49):17212-17222. PubMed ID: 36459499
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
Wang J; Gao T; Luo Y; Wang Z; Zhang Y; Zhang Y; Zhang Y; Pei R
J Mol Evol; 2019 Apr; 87(2-3):72-82. PubMed ID: 30659315
[TBL] [Abstract][Full Text] [Related]
4. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
5. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.
Zhang L; Wang M; Zhu Z; Ding C; Chen S; Wu H; Yang Y; Che F; Li Q; Li H
Int J Nanomedicine; 2021; 16():3217-3240. PubMed ID: 34007175
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
7. Cancer biomarker discovery using DNA aptamers.
Jin C; Qiu L; Li J; Fu T; Zhang X; Tan W
Analyst; 2016 Jan; 141(2):461-6. PubMed ID: 26567694
[TBL] [Abstract][Full Text] [Related]
8. Generating aptamers by cell-SELEX for applications in molecular medicine.
Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
[TBL] [Abstract][Full Text] [Related]
9. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
10. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
11. Identification of PHB2 as a Potential Biomarker of Luminal A Breast Cancer Cells Using a Cell-Specific Aptamer.
Liu M; Wang Z; Li S; Deng Y; He N
ACS Appl Mater Interfaces; 2022 Nov; 14(46):51593-51601. PubMed ID: 36346944
[TBL] [Abstract][Full Text] [Related]
12. Aptamers selected by cell-SELEX for application in cancer studies.
Zhang Y; Chen Y; Han D; Ocsoy I; Tan W
Bioanalysis; 2010 May; 2(5):907-18. PubMed ID: 20657791
[TBL] [Abstract][Full Text] [Related]
13. Cancer protein biomarker discovery based on nucleic acid aptamers.
Xiong H; Yan J; Cai S; He Q; Peng D; Liu Z; Liu Y
Int J Biol Macromol; 2019 Jul; 132():190-202. PubMed ID: 30926499
[TBL] [Abstract][Full Text] [Related]
14. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
[TBL] [Abstract][Full Text] [Related]
15. Aptamers: new arrows to target dendritic cells.
Ganji A; Varasteh A; Sankian M
J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
[TBL] [Abstract][Full Text] [Related]
16. ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells.
Yu G; Li H; Yang S; Wen J; Niu J; Zu Y
PLoS One; 2016; 11(1):e0147674. PubMed ID: 26808385
[TBL] [Abstract][Full Text] [Related]
17. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in protein and cell-targeted aptamer selection and applications.
Liu J; You M; Pu Y; Liu H; Ye M; Tan W
Curr Med Chem; 2011; 18(27):4117-25. PubMed ID: 21838693
[TBL] [Abstract][Full Text] [Related]
19. Metastatic cancer cell and tissue-specific fluorescence imaging using a new DNA aptamer developed by Cell-SELEX.
Yuan B; Jiang X; Chen Y; Guo Q; Wang K; Meng X; Huang Z; Wen X
Talanta; 2017 Aug; 170():56-62. PubMed ID: 28501211
[TBL] [Abstract][Full Text] [Related]
20. Novel HER2 aptamer selectively delivers cytotoxic drug to HER2-positive breast cancer cells in vitro.
Liu Z; Duan JH; Song YM; Ma J; Wang FD; Lu X; Yang XD
J Transl Med; 2012 Jul; 10():148. PubMed ID: 22817844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]